Inappropriate Sinus Tachycardia Registry
A Multicenter Patient Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment
AtriCure, Inc.
500 participants
Mar 1, 2022
OBSERVATIONAL
Conditions
Summary
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Eligibility
Inclusion Criteria2
- Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
- Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements
Exclusion Criteria1
- Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05107635